195 related articles for article (PubMed ID: 2668407)
1. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.
Pollare T; Lithell H; Mörlin C; Präntare H; Hvarfner A; Ljunghall S
J Hypertens; 1989 Jul; 7(7):551-9. PubMed ID: 2668407
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
Pollare T; Lithell H; Selinus I; Berne C
BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
Andersson PE; Johansson J; Berne C; Lithell H
J Hum Hypertens; 1994 Mar; 8(3):219-26. PubMed ID: 8006923
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of antihypertensive therapy with a calcium antagonist.
Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; DiPette DJ; Evans RR
Am J Cardiol; 1988 Oct; 62(11):109G-113G. PubMed ID: 3051991
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
[TBL] [Abstract][Full Text] [Related]
6. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol.
Luurila OJ; Gröhn P; Heikkilä J; Hämäläinen L; Härkönen R; Idänpään-Heikkilä U; Kohvakka A; Rytkönen U; Setälä M; Sundberg S
Am J Cardiol; 1987 Oct; 60(10):832-5. PubMed ID: 3310576
[TBL] [Abstract][Full Text] [Related]
7. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.
Eriksson JW; Jansson PA; Foley K; Lithell H
J Hypertens; 1996 Dec; 14(12):1469-75. PubMed ID: 8986932
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the metabolic effects of captopril and atenolol on glucose, insulin and lipoproteins in patients with mild-to-moderate essential hypertension.
Maritz FJ; Weich HF; Schoeman HS
S Afr Med J; 1995 Dec; 85(12 Pt 2):1342-5. PubMed ID: 8600607
[TBL] [Abstract][Full Text] [Related]
9. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
Myburgh DP; Gordon NF
Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
Lacourcière Y; Poirier L; Boucher S; Spenard J
J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects.
Dujovne CA; Eff J; Ferraro L; Goldstein RJ; Gotto AM; Hall WD; Harris WS; Held SJ; Herd A; Hunninghake DB
Am J Cardiol; 1993 Nov; 72(15):1131-6. PubMed ID: 8237801
[TBL] [Abstract][Full Text] [Related]
12. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension.
Sheu WH; Swislocki AL; Hoffman B; Chen YD; Reaven GM
Am J Hypertens; 1991 Mar; 4(3 Pt 1):199-205. PubMed ID: 2043298
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary response during exercise of a beta 1-selective beta-blocker (atenolol) and a calcium-channel blocker (diltiazem) in untrained subjects with hypertension.
Cohen-Solal A; Baleynaud S; Laperche T; Sebag C; Gourgon R
J Cardiovasc Pharmacol; 1993 Jul; 22(1):33-8. PubMed ID: 7690093
[TBL] [Abstract][Full Text] [Related]
15. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Lakshman MR; Reda DJ; Materson BJ; Cushman WC; Freis ED
Arch Intern Med; 1999 Mar; 159(6):551-8. PubMed ID: 10090111
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of a change in antihypertensive treatment.
Lithell H; Aberg H; Selinus I
Am J Med; 1986 Feb; 80(2A):114-9. PubMed ID: 3511690
[TBL] [Abstract][Full Text] [Related]
17. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.
Houston MC; Burger C; Hays JT; Nadeau J; Swift L; Bradley CA; Olafsson L
Am Heart J; 1990 Jul; 120(1):172-9. PubMed ID: 2193493
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.
Pollare T; Lithell H; Berne C
N Engl J Med; 1989 Sep; 321(13):868-73. PubMed ID: 2671740
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
Thulin T; Lehtonen A; Dahlöf C; Nilsson-Ehle P; Engqvist L; Lagerstedt C; Berglund E
Int J Clin Pharmacol Ther; 1999 Jan; 37(1):28-33. PubMed ID: 10027480
[TBL] [Abstract][Full Text] [Related]
20. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
